Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

262.64
Delayed Data
As of May 26
 +1.18 / +0.45%
Today’s Change
128.50
Today|||52-Week Range
349.08
+68.36%
Year-to-Date

Today’s Trading

Previous close261.46
Today’s open260.00
Day’s range255.55 - 263.98
Volume535,485
Average volume (3 months)649,305
Market cap$6.3B
Dividend yield--
Data as of 05/26/2015

Growth & Valuation

Earnings growth (last year)-262.50%
Earnings growth (this year)+34.86%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+7.40%
P/E ratioNM
Price/Sales1,861.70
Price/Book24.25

Competitors

 Today’s
change
Today’s
% change
PBYIPuma Biotechnology I...+7.61+3.99%
IDXXIDEXX Laboratories I...-0.91-0.66%
TAROTaro Pharmaceutical ...-0.61-0.44%
SGENSeattle Genetics Inc-0.42-0.97%
Data as of 05/26/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)-$2.00
Annual revenue (last year)$1.7M
Annual profit (last year)-$283.2M
Net profit margin-16,262.23%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer, Secretary &
Treasurer
Barbara Gayle Duncan
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers